Sensyne Algorithm For COVID-19 Risk Prediction Gets UK Regulatory Approval
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.
You may also be interested in...
The business founded by Lord Drayson has struggled to achieve commercial success for its artificial intelligence products.
MeMed’s test measures immune system response to assess a patient’s COVID-19 trajectory.
Sensyne has licensed its MagnifEye artificial intelligence technology to Excalibur Healthcare to improve the detection of COVID-19 infection at low viral loads.